Susquehanna International Group, LLP Immutep LTD Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Immutep LTD stock. As of the latest transaction made, Susquehanna International Group, LLP holds 47,457 shares of IMMP stock, worth $75,456. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,457
Previous 116,119
59.13%
Holding current value
$75,456
Previous $251,000
66.93%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding IMMP
# of Institutions
28Shares Held
1.83MCall Options Held
66.5KPut Options Held
36.3K-
Black Rock Inc. New York, NY839KShares$1.33 Million0.0% of portfolio
-
Meridian Wealth Management, LLC387KShares$614,7730.03% of portfolio
-
Xy Capital LTD Central, K3137KShares$217,4220.07% of portfolio
-
Steward Partners Investment Advisory, LLC61KShares$96,9900.0% of portfolio
-
Jane Street Group, LLC New York, NY51.6KShares$82,0020.0% of portfolio
About IMMUTEP Ltd
- Ticker IMMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,000
- Market Cap $138M
- Description
- Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...